Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study

Man‐Fung Yuen, Robert Pleśniak, Seng Gee Lim, Keiji Tsuji, Gheorghe Diaconescu, Adrián Gadano, Ju Hyun Kim, Tarik Asselah, Hyung Joon Yim, Jeong Heo, Giuliano Rizzardini, Harry L.a. Janssen, Corneliu Petru Popescu, Diana Petrova, Alexander Wong, Nevin Indriz, Cristina Pojoga, Yasuhito Tanaka, Д. А. Гусев, Ewa Janczewska, Jennifer Cremer, Robert C. Elston, Tamara Lukić, Lauren Maynard, Stuart Kendrick, Punam Bharania, Fiona Campbell, Melanie Paff, Dickens TheodoreJournal of Hepatology 2022 · DOI

BibTeX
@article{yuen2022efficacy,
  author = {Man‐Fung Yuen and Robert Pleśniak and Seng Gee Lim and Keiji Tsuji and Gheorghe Diaconescu and Adrián Gadano and Ju Hyun Kim and Tarik Asselah and Hyung Joon Yim and Jeong Heo and Giuliano Rizzardini and Harry L.A. Janssen and Corneliu Petru Popescu and Diana Petrova and Alexander Wong and Nevin Indriz and Cristina Pojoga and Yasuhito Tanaka and Д. А. Гусев and Ewa Janczewska and Jennifer Cremer and Robert C. Elston and Tamara Lukić and Lauren Maynard and Stuart Kendrick and Punam Bharania and Fiona Campbell and Melanie Paff and Dickens Theodore},
  title = {{Efficacy and safety of bepirovirsen in patients with chronic hepatitis B virus infection on stable nucleos (t)ide analogue therapy: interim results from the randomised phase 2b B-Clear study}},
  journal = {Journal of Hepatology},
  year = {2022},
  doi = {10.1016/s0168-8278(22)02055-4},
}

Loading related content...

Figure